VA and IBM Watson Health Extend Partnership to Support Veterans With Cancer
Retrieved on:
Thursday, July 19, 2018
First announced two years ago as part of the National Cancer Moonshot Initiative , VA oncologists have now used IBM Watson for Genomics technology to support precision oncology care for more than 2,700 Veterans with cancer.
Key Points:
- First announced two years ago as part of the National Cancer Moonshot Initiative , VA oncologists have now used IBM Watson for Genomics technology to support precision oncology care for more than 2,700 Veterans with cancer.
- By knowing the cancer genome, oncologists and patients are able to choose therapies that specifically target the patient's cancer.
- The partnership extension with IBM will enable VA oncologists to continue using Watson for Genomics through at least June 2019.
- VA treats 3.5 percent of the nation's cancer patients the largest group of cancer patients within any one health-care group.